The outs and the ins of sphingosine-1-phosphate in immunity

Nature Reviews Immunology

Volumn 11, Issue 6, 2011, Pages 403-415

  Spiegel, Sarah ^a   Milstien, Sheldon ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; CHEMOKINE RECEPTOR CCR7; FINGOLIMOD; HISTAMINE; HISTONE DEACETYLASE; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; KRUPPEL LIKE FACTOR 2; LX 2931; LYASE INHIBITOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEINASE ACTIVATED RECEPTOR 1; RECEPTOR INTERACTING PROTEIN 140; RHO KINASE; SECONDARY LYMPHOID TISSUE CHEMOKINE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UNCLASSIFIED DRUG;

ASTHMA; B LYMPHOCYTE; BLOOD VESSEL PERMEABILITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; DENDRITIC CELL; ENZYME INDUCTION; ENZYME METABOLISM; ENZYME SYNTHESIS; GENE TARGETING; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNITY; INFLAMMATION; INNATE IMMUNITY; LYMPHOCYTE FUNCTION; LYMPHOID TISSUE; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MAST CELL; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NEUTROPHIL; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; RHEUMATOID ARTHRITIS; SEPSIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE; THYMOCYTE;

ANIMALS; HUMANS; IMMUNITY; INFLAMMATION; LYSOPHOSPHOLIPIDS; MODELS, IMMUNOLOGICAL; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RECEPTORS, LYSOSPHINGOLIPID; SECOND MESSENGER SYSTEMS; SPHINGOSINE;

EID: 79957610938     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri2974     Document Type: Review

References (108)

1. Zhang, H. et al. Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation. J. Cell Biol. 114, 155-167 (1991). (Pubitemid 21909788)
2. Olivera, A. & Spiegel, S. Sphingosine-1-phosphate as a second messenger in cell proliferation induced by PDGF and FCS mitogens. Nature 365, 557-560 (1993). (Pubitemid 23317779)
3. Spiegel, S. & Milstien, S. Functions of the multifaceted family of sphingosine kinases and some close relatives. J. Biol. Chem. 282, 2125-2129 (2007). (Pubitemid 47076736)
4. Spiegel, S. & Milstien, S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nature Rev. Mol. Cell Biol. 4, 397-407 (2003). (Pubitemid 36565571)
5. Schwab, S. R. et al. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science 309, 1735-1739 (2005). (Pubitemid 41285945)
6. Pappu, R. et al. Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science 316, 295-298 (2007). (Pubitemid 46633109)
7. Pham, T. H. et al. Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning. J. Exp. Med. 207, 17-27 (2010).
8. Schwab, S. R. & Cyster, J. G. Finding a way out: lymphocyte egress from lymphoid organs. Nature Immunol. 8, 1295-1301 (2007). (Pubitemid 350131168)
9. Rivera, J., Proia, R. L. & Olivera, A. The alliance of sphingosine-1-phosphate and its receptors in immunity. Nature Rev. Immunol. 8, 753-763 (2008).
10. Pereira, J. P., Kelly, L. M. & Cyster, J. G. Finding the right niche: B-cell migration in the early phases of T-dependent antibody responses. Int. Immunol. 22, 413-419 (2010).
11. Chi, H. Sphingosine-1-phosphate and immune regulation: trafficking and beyond. Trends Pharmacol. Sci. 32, 16-24 (2011).
12. Wang, F. et al. Sphingosine 1-phosphate stimulates cell migration through a Gi-coupled cell surface receptor. Potential involvement in angiogenesis. J. Biol. Chem. 274, 35343-35350 (1999). (Pubitemid 129512822)
13. Zachariah, M. A. & Cyster, J. G. Neural crest-derived pericytes promote egress of mature thymocytes at the corticomedullary junction. Science 328, 1129-1135 (2010).
14. Cinamon, G., Zachariah, M. A., Lam, O. M., Foss, F. W. Jr & Cyster, J. G. Follicular shuttling of marginal zone B cells facilitates antigen transport. Nature Immunol. 9, 54-62 (2008). (Pubitemid 350286204)
15. Jenne, C. N. et al. T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow. J. Exp. Med. 206, 2469-2481 (2009).
16. Rathinasamy, A., Czeloth, N., Pabst, O., Forster, R. & Bernhardt, G. The origin and maturity of dendritic cells determine the pattern of sphingosine 1-phosphate receptors expressed and required for efficient migration. J. Immunol. 185, 4072-4081 (2010).
17. Konig, K. et al. Four-and-a-half LIM domain protein 2 is a novel regulator of sphingosine 1-phosphate receptor 1 in CCL19-induced dendritic cell migration. J. Immunol. 185, 1466-1475 (2010).
18. Jolly, P. S. et al. Transactivation of sphingosine-1-phosphate receptors by FcεRI triggering is required for normal mast cell degranulation and chemotaxis. J. Exp. Med. 199, 959-970 (2004). (Pubitemid 38481087)
19. Ishii, M. et al. Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. Nature 458, 524-528 (2009).
20. Grigorova, I. L. et al. Cortical sinus probing, S1P1-dependent entry and flow-based capture of egressing T cells. Nature Immunol. 10, 58-65 (2009).
21. Allende, M. L. et al. S1P1 receptor directs the release of immature B cells from bone marrow into blood. J. Exp. Med. 207, 1113-1124 (2010).
22. Sinha, R. K., Park, C., Hwang, I. Y., Davis, M. D. & Kehrl, J. H. B lymphocytes exit lymph nodes through cortical lymphatic sinusoids by a mechanism independent of sphingosine-1-phosphate-mediated chemotaxis. Immunity 30, 434-446 (2009).
23. Takada, K. et al. Kruppel-like factor 2 is required for trafficking but not quiescence in postactivated T cells. J. Immunol. 186, 775-783 (2011).
24. Sensken, S. C. et al. Redistribution of sphingosine 1-phosphate by sphingosine kinase 2 contributes to lymphopenia. J. Immunol. 184, 4133-4142 (2010).
25. Gossens, K. et al. Thymic progenitor homing and lymphocyte homeostasis are linked via S1P-controlled expression of thymic P-selectin/CCL25. J. Exp. Med. 206, 761-778 (2009).
26. Thangada, S. et al. Cell-surface residence of sphingosine 1-phosphate receptor 1 on lymphocytes determines lymphocyte egress kinetics. J. Exp. Med. 207, 1475-1483 (2010).
27. Pham, T. H., Okada, T., Matloubian, M., Lo, C. G. & Cyster, J. G. S1P1 receptor signaling overrides retention mediated by Gαi-coupled receptors to promote T cell egress. Immunity 28, 122-133 (2008).
28. Grigorova, I. L., Panteleev, M. & Cyster, J. G. Lymph node cortical sinus organization and relationship to lymphocyte egress dynamics and antigen exposure. Proc. Natl Acad. Sci. USA 107, 20447-20452 (2010).
29. Bankovich, A. J., Shiow, L. R. & Cyster, J. G. CD69 suppresses sphingosine 1-phosophate receptor-1 (S1P1) function through interaction with membrane helix 4. J. Biol. Chem. 285, 22328-22337 (2010).
30. Maeda, Y., Seki, N., Sato, N., Sugahara, K. & Chiba, K. Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow. Int. Immunol. 22, 515-525 (2010).
31. Cyster, J. G. B cell follicles and antigen encounters of the third kind. Nature Immunol. 11, 989-996 (2010).
32. Hoek, K. L. et al. Follicular B cell trafficking within the spleen actively restricts humoral immune responses. Immunity 33, 254-265 (2010).
33. Hart, G. T., Wang, X., Hogquist, K. A. & Jameson, S. C. Kruppel-like factor 2 (KLF2) regulates B-cell reactivity, subset differentiation, and trafficking molecule expression. Proc. Natl Acad. Sci. USA 108, 716-721 (2011).
34. Winkelmann, R. et al. B cell homeostasis and plasma cell homing controlled by Kruppel-like factor 2. Proc. Natl Acad. Sci. USA 108, 710-715 (2011).
35. Pereira, J. P., Cyster, J. G. & Xu, Y. A role for S1P and S1P1 in immature-B cell egress from mouse bone marrow. PLoS ONE 5, e9277 (2010).
36. Donovan, E. E., Pelanda, R. & Torres, R. M. S1P3 confers differential S1P-induced migration by autoreactive and non-autoreactive immature B cells and is required for normal B-cell development. Eur. J. Immunol. 40, 688-698 (2010).
37. Faroudi, M. et al. Critical roles for Rac GTPases in T-cell migration to and within lymph nodes. Blood 116, 5536-5547 (2010).
38. Sakata, D. et al. Impaired T lymphocyte trafficking in mice deficient in an actin-nucleating protein, mDia1. J. Exp. Med. 204, 2031-2038 (2007). (Pubitemid 47360865)
39. Liu, Y. et al. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J. Clin. Invest. 106, 951-961 (2000).
40. Wang, F. et al. Sphingosine-1-phosphate receptor-2 deficiency leads to inhibition of macrophage proinflammatory activities and atherosclerosis in apoE-deficient mice. J. Clin. Invest. 120, 3979-3995 (2010).
41. Walzer, T. et al. Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. Nature Immunol. 8, 1337-1344 (2007). (Pubitemid 350131171)
42. Vogel, P. et al. Incomplete inhibition of sphingosine 1-phosphate lyase modulates immune system function yet prevents early lethality and non-lymphoid lesions. PLoS ONE 4, e4112 (2009).
43. Allende, M. L. et al. Sphingosine-1-phosphate lyase deficiency produces a pro-inflammatory response while impairing neutrophil trafficking. J. Biol. Chem. 286, 7348-7358 (2010).
44. Garcia, J. G. et al. Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J. Clin. Invest. 108, 689-701 (2001). (Pubitemid 32906197)
45. Dudek, S. M. et al. Abl tyrosine kinase phosphorylates nonmuscle myosin light chain kinase to regulate endothelial barrier function. Mol. Biol. Cell 21, 4042-4056 (2010).
46. Camerer, E. et al. Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice. J. Clin. Invest. 119, 1871-1879 (2009).
47. Marsolais, D. & Rosen, H. Chemical modulators of sphingosine-1- phosphate receptors as barrier-oriented therapeutic molecules. Nature Rev. Drug Discov. 8, 297-307 (2009).
48. Sanchez, T. et al. Induction of vascular permeability by the sphingosine-1-phosphate receptor-2 (S1P2R) and its downstream effectors ROCK and PTEN. Arterioscler. Thromb. Vasc. Biol. 27, 1312-1318 (2007). (Pubitemid 46809419)
49. Niessen, F. et al. Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation. Nature 452, 654-658 (2008). (Pubitemid 351483355)
50. Olivera, A. et al. IgE-dependent activation of sphingosine kinases 1 and 2 and secretion of sphingosine 1-phosphate requires Fyn kinase and contributes to mast cell responses. J. Biol. Chem. 281, 2515-2525 (2006). (Pubitemid 43845711)
51. Olivera, A. et al. The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis. Immunity 26, 287-297 (2007). (Pubitemid 46413904)
52. Oskeritzian, C. A. et al. Distinct roles of sphingosine kinases 1 and 2 in human mast-cell functions. Blood 111, 4193-4200 (2008).
53. Mitra, P. et al. Role of ABCC1 in export of sphingosine-1-phosphate from mast cells. Proc. Natl Acad. Sci. USA 103, 16394-16399 (2006). (Pubitemid 44715207)
54. Osborne, N. et al. The spinster homolog, two of hearts, is required for sphingosine 1-phosphate signaling in zebrafish. Curr. Biol. 18, 1882-1888 (2008).
55. Kawahara, A. et al. The sphingolipid transporter Spns2 functions in migration of zebrafish myocardial precursors. Science 323, 524-527 (2009).
56. Nishiuma, T. et al. Inhalation of sphingosine kinase inhibitor attenuates airway inflammation in asthmatic mouse model. Am. J. Physiol. Lung Cell. Mol. Physiol. 294, L1085-L1093 (2008).
57. Price, M. M. et al. Sphingosine-1-phosphate induces development of functionally mature chymase-expressing human mast cells from hematopoietic progenitors. FASEB J. 23, 3506-3515 (2009).
58. Oskeritzian, C. A. et al. Essential roles of sphingosine-1-phosphate receptor 2 in human mast cell activation, anaphylaxis, and pulmonary edema. J. Exp. Med. 207, 465-474 (2010).
59. Sun, X. et al. Functional variants of the sphingosine-1-phosphate receptor 1 gene associate with asthma susceptibility. J. Allergy Clin. Immunol. 126, 241-249 (2010).
60. Olivera, A. et al. Sphingosine kinase 1 and sphingosine-1-phosphate receptor 2 are vital to recovery from anaphylactic shock in mice. J. Clin. Invest. 120, 1429-1240 (2010).
61. Niessen, F. et al. Endogenous EPCR/aPC-PAR1 signaling prevents inflammation-induced vascular leakage and lethality. Blood 113, 2859-2866 (2009).
62. Tauseef, M. et al. Activation of sphingosine kinase-1 reverses the increase in lung vascular permeability through sphingosine-1-phosphate receptor signaling in endothelial cells. Circ. Res. 103, 1164-1172 (2008).
63. Sammani, S. et al. Differential effects of sphingosine 1-phosphate receptors on airway and vascular barrier function in the murine lung. Am. J. Respir. Cell. Mol. Biol. 43, 394-402 (2010).
64. Xia, P. et al. Tumor necrosis factor-α induces adhesion molecule expression through the sphingosine kinase pathway. Proc. Natl Acad. Sci. USA 95, 14196-14201 (1998). (Pubitemid 28549344)
65. Snider, A. J. et al. A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis. FASEB J. 23, 143-152 (2008).
66. Lai, W. Q. et al. Distinct roles of sphingosine kinase 1 and 2 in murine collagen-induced arthritis. J. Immunol. 183, 2097-2103 (2009).
67. Baker, D. A., Barth, J., Chang, R., Obeid, L. M. & Gilkeson, G. S. Genetic sphingosine kinase 1 deficiency significantly decreases synovial inflammation and joint erosions in murine TNF-α-induced arthritis. J. Immunol. 185, 2570-2579 (2010).
68. Pitson, S. M. et al. Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation. EMBO J. 22, 5491-5500 (2003). (Pubitemid 37279958)
69. Takabe, K., Paugh, S. W., Milstien, S. & Spiegel, S. "Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets. Pharmacol. Rev. 60, 181-195 (2008). (Pubitemid 351962008)
70. De Palma, C., Meacci, E., Perrotta, C., Bruni, P. & Clementi, E. Endothelial nitric oxide synthase activation by tumor necrosis factor α through neutral sphingomyelinase 2, sphingosine kinase 1, and sphingosine 1 phosphate receptors: a novel pathway relevant to the pathophysiology of endothelium. Arterioscler. Thromb. Vasc. Biol. 26, 99-105 (2006). (Pubitemid 43732234)
71. Scherer, E. Q. et al. Tumor necrosis factor-α enhances microvascular tone and reduces blood flow in the cochlea via enhanced sphingosine-1-phosphate signaling. Stroke 41, 2618-2624 (2010).
72. Vann, L. R. et al. Involvement of sphingosine kinase in TNF-α-stimulated tetrahydrobiopterin biosynthesis in C6 glioma cells. J. Biol. Chem. 277, 12649-12656 (2002). (Pubitemid 34952624)
73. Xia, P. et al. Sphingosine kinase interacts with TRAF2 and dissects tumor necrosis factor-α signaling. J. Biol. Chem. 277, 7996-8003 (2002). (Pubitemid 34968251)
74. Siehler, S., Wang, Y., Fan, X., Windh, R. T. & Manning, D. R. Sphingosine 1-phosphate activates nuclear factor-κB through Edg receptors. Activation through Edg-3 and Edg-5, but not Edg-1, in human embryonic kidney 293 cells. J. Biol. Chem. 276, 48733-48739 (2001).
75. Alvarez, S. E. et al. Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature 465, 1084-1088 (2010).
76. Bhoj, V. G. & Chen, Z. J. Ubiquitylation in innate and adaptive immunity. Nature 458, 430-437 (2009).
77. Lee, T. H., Shank, J., Cusson, N. & Kelliher, M. A. The kinase activity of Rip1 is not required for tumor necrosis factor-α-induced IκB kinase or p38 MAP kinase activation or for the ubiquitination of Rip1 by Traf2. J. Biol. Chem. 279, 33185-33191 (2004). (Pubitemid 39062963)
78. Li, S., Wang, L. & Dorf, M. E. PKC phosphorylation of TRAF2 mediates IKKα/β recruitment and K63-linked polyubiquitination. Mol. Cell 33, 30-42 (2009).
79. Varfolomeev, E. et al. c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor α (TNFα)-induced NF-κB activation. J. Biol. Chem. 283, 24295-24299 (2008).
80. Ea, C. K., Deng, L., Xia, Z. P., Pineda, G. & Chen, Z. J. Activation of IKK by TNFα requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol. Cell 22, 245-257 (2006).
81. Wu, C. J., Conze, D. B., Li, T., Srinivasula, S. M. & Ashwell, J. D. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-κB activation [corrected]. Nature Cell Biol. 8, 398-406 (2006).
82. Devin, A., Lin, Y. & Liu, Z. G. The role of the death-domain kinase RIP in tumour-necrosis-factor-induced activation of mitogen-activated protein kinases. EMBO Rep. 4, 623-627 (2003). (Pubitemid 36939955)
83. Paugh, B. S. et al. EGF regulates plasminogen activator inhibitor-1 (PAI-1) by a pathway involving c-Src, PKCδ, and sphingosine kinase 1 in glioblastoma cells. FASEB J. 22, 455-465 (2008). (Pubitemid 351225582)
84. Deshaies, R. J. & Joazeiro, C. A. RING domain E3 ubiquitin ligases. Annu. Rev. Biochem. 78, 399-434 (2009).
85. Wu, W., Mosteller, R. D. & Broek, D. Sphingosine kinase protects lipopolysaccharide-activated macrophages from apoptosis. Mol. Cell. Biol. 24, 7359-7369 (2004). (Pubitemid 39121466)
86. Puneet, P. et al. SphK1 regulates proinflammatory responses associated with endotoxin and polymicrobial sepsis. Science 328, 1290-1294 (2010).
87. Keul, P. et al. Sphingosine-1-phosphate receptor 3 promotes recruitment of monocyte/macrophages in inflammation and atherosclerosis. Circ. Res. 108, 314-323 (2011).
88. Skoura, A. et al. Sphingosine-1-phosphate receptor-2 function in myeloid cells regulates vascular inflammation and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 31, 81-85 (2011).
89. Hughes, J. E. et al. Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages. Circ. Res. 102, 950-958 (2008). (Pubitemid 351591554)
90. Eskan, M. A. et al. TLR4 and S1P receptors cooperate to enhance inflammatory cytokine production in human gingival epithelial cells. Eur. J. Immunol. 38, 1138-1147 (2008).
91. Vallabhapurapu, S. & Karin, M. Regulation and function of NF-κB transcription factors in the immune system. Annu. Rev. Immunol. 27, 693-733 (2009).
92. Nayak, D. et al. Sphingosine kinase 1 regulates the expression of proinflammatory cytokines and nitric oxide in activated microglia. Neuroscience 166, 132-144 (2010).
93. Di, A. et al. A novel function of sphingosine kinase 1 suppression of JNK activity in preventing inflammation and injury. J. Biol. Chem. 285, 15848-15857 (2010).
94. Samy, E. T. et al. Cutting edge: modulation of intestinal autoimmunity and IL-2 signaling by sphingosine kinase 2 independent of sphingosine 1-phosphate. J. Immunol. 179, 5644-5648 (2007).
95. Hait, N. C. et al. Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science 325, 1254-1257 (2009).
96. Haberland, M., Montgomery, R. L. & Olson, E. N. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nature Rev. Genet. 10, 32-42 (2009).
97. Glauben, R., Sonnenberg, E., Zeitz, M. & Siegmund, B. HDAC inhibitors in models of inflammation-related tumorigenesis. Cancer Lett. 280, 154-159 (2009).
98. + regulatory T cells. Nature Rev. Drug Discov. 8, 969-981 (2009).
99. Igarashi, N. et al. Sphingosine kinase 2 is a nuclear protein and inhibits DNA synthesis. J. Biol. Chem. 278, 46832-46839 (2003). (Pubitemid 37452263)
100. Sankala, H. M. et al. Involvement of sphingosine kinase 2 in p53-independent induction of p21 by the chemotherapeutic drug doxorubicin. Cancer Res. 67, 10466-10474 (2007). (Pubitemid 350070822)
101. Hait, N. C., Bellamy, A., Milstien, S., Kordula, T. & Spiegel, S. Sphingosine kinase type 2 activation by ERK-mediated phosphorylation. J. Biol. Chem. 282, 12058-12065 (2007). (Pubitemid 47100715)
102. Ding, G. et al. Protein kinase D-mediated phosphorylation and nuclear export of sphingosine kinase 2. J. Biol. Chem. 282, 27493-27502 (2007). (Pubitemid 47501982)
103. Brinkmann, V. et al. Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nature Rev. Drug Discov. 9, 883-897 (2010).
104. Mullershausen, F. et al. Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors. Nature Chem. Biol. 5, 428-434 (2009).
105. Mehling, M. et al. FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis. Neurology 71, 1261-1267 (2008).
106. Choi, J. W. et al. FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation. Proc. Natl Acad. Sci. USA 108, 751-756 (2010).
107. Kulakowska, A. et al. Intrathecal increase of sphingosine 1-phosphate at early stage multiple sclerosis. Neurosci. Lett. 477, 149-152 (2010).
108. Bagdanoff, J. T. et al. Inhibition of sphingosine 1-phosphate lyase for the treatment of rheumatoid arthritis: discovery of (E)-1-(4-((1R,2S,3R)-1,2,3, 4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanoneoxime (LX2931) and (1R,2S,3R)-1-(2-(isoxazol-3-yl)-1H-imidazol-4-yl)butane-1,2,3,4-tetraol (LX2932). J. Med. Chem. 53, 8650-8662 (2010).